Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol
We report the outcome for children and young people with Down syndrome-associated acute lymphoblastic leukaemia (DS-ALL) treated on a contemporary protocol. Compared with non-DS ALL, patients with DS-ALL had an inferior event-free survival (65·6% vs. 87·7% at 5 years; P < 0·00005) and overall...
প্রধান লেখক: | Patrick, K, Wade, R, Goulden, N, Rowntree, C, Hough, R, Moorman, A, Mitchell, C, Vora, A |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
Blackwell Publishing Ltd
2014
|
অনুরূপ উপাদানগুলি
-
Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
অনুযায়ী: Patrick, K, অন্যান্য
প্রকাশিত: (2014) -
Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
অনুযায়ী: Patrick, K, অন্যান্য
প্রকাশিত: (2014) -
Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
অনুযায়ী: Patrick, K, অন্যান্য
প্রকাশিত: (2014) -
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
অনুযায়ী: Vora, A, অন্যান্য
প্রকাশিত: (2014) -
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
অনুযায়ী: Vora, A, অন্যান্য
প্রকাশিত: (2014)